Melus

Meloxicam, the active ingredient in Melus, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other musculoskeletal disorders.

GNH USA supplies Melus as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID used to manage inflammatory joint diseases and related pain. - Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: alleviates inflammation and slows disease progression. - Ankylosing spondylitis: diminishes spinal stiffness and discomfort. - Acute pain: provides short‑term relief of moderate to severe pain.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema. - Skin rash or pruritus. - Elevated blood pressure.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic injury with elevated transaminases. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Renal impairment or failure. - Anaphylactic or severe hypersensitivity reactions.

Before initiating meloxicam, clinicians should consider patient‑specific risk factors and monitor therapy appropriately. - Gastrointestinal risk assessment: evaluate history of ulcer disease or bleeding. - Cardiovascular monitoring: watch for hypertension or thrombotic events. - Renal and hepatic function: check baseline labs and adjust if impairment exists. - Concomitant medications: avoid unnecessary NSAID combinations. - Hypersensitivity: discontinue if signs of severe allergy appear. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may reduce renal perfusion. - Lithium: elevated serum lithium levels. - High‑dose aspirin: potentiates antiplatelet effect.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive efficacy. - Methotrexate: decreased clearance leading to toxicity. - Corticosteroids: heightened risk of gastrointestinal ulceration. - SSRIs: modest increase in bleeding tendency. - Antihypertensives: may blunt blood pressure control.